ATI PN Pharmacology 2020 Exam 2 Updated 2024
ATI PN Pharmacology 2020 Exam 2 Updated 2024 ( 57 Questions)
A nurse is administering spironolactone at 0800 to a client who has heart failure. The nurse should monitor the client for which of the following adverse effects?
Spironolactone is not associated with hypophosphatemia.
Spironolactone is a potassium-sparing diuretic, and hyperkalemia is a potential adverse effect due to reduced potassium excretion.
Spironolactone is not associated with hypocalcemia.
Spironolactone is not associated with hypernatremia; rather, it promotes sodium excretion.
A. Spironolactone is not associated with hypophosphatemia.
B. Spironolactone is a potassium-sparing diuretic, and hyperkalemia is a potential adverse effect due to reduced potassium excretion.
C. Spironolactone is not associated with hypocalcemia.
D. Spironolactone is not associated with hypernatremia; rather, it promotes sodium excretion.